Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Following a review process conducted with the assistance of its legal and financial advisors, the Kronos Bio Board of Directors has determined that the acquisition by Concentra is in the best ...

The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...

“This is a clear and deliberate shift,” Corbett says.

Many companies have foreshadowed deals to come during earnings calls in recent days. The return of M&A would be a welcome ...

Merlin is engaged in lease negotiations to use a former Navy hangar on a nearly 19-acre parcel on the north edge of the ...

Discover United Therapeutics' Q1 2025 earnings insights: record revenues, growth strategies, and pipeline advancements.

We recently published a list of The Best and Worst Dow Stocks for the Next 12 Months. In this article, we are going to take a look at where Merck & Co. Inc.

When it comes to vaccination, the COVID-19 pandemic divided American society. President Donald Trump and his new Health and ...

Hospitals across the country are starting to reckon with the effects President Trump's tariffs are having on medical supplies ...

Despite the outperformance, the payer’s stock was largely flat following the earnings release — a market reaction that ...

Wall Street analysts downgraded Regulus Therapeutics on Wednesday following its acquisition by Swiss drugmaker Novartis, ...